NCT00001277 2022-06-07Studies of Elevated Parathyroid ActivityNational Institutes of Health Clinical Center (CC)Phase 2 Completed1,553 enrolled 8 charts
NCT00947167 2017-03-03A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine TumorsStanford UniversityPhase 2 Terminated4 enrolled 5 charts